Reducing Cardiometabolic Risk and Promoting Functional Health in Older Adults With Obesity and Prediabetes
Sustain-DPP
2 other identifiers
interventional
314
1 country
1
Brief Summary
Obesity and pre-diabetes threatens the overall health and functional independence of older adults but lifestyle weight management for diabetes prevention, soon to be reimbursed by Medicare, can reduce this burden. The current 24-month study will enroll adults, ages 60 and older, through senior community centers and research registries. The investigators will study how two long term weight loss maintenance programs, both using group telephone sessions to support health behavior change, impact meaningful health outcomes. If successful, this project will provide a sustainable intervention model for healthy aging services that can benefit older adults and society.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Mar 2018
Longer than P75 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2018
CompletedStudy Start
First participant enrolled
March 27, 2018
CompletedFirst Posted
Study publicly available on registry
April 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 27, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2023
CompletedResults Posted
Study results publicly available
August 15, 2024
CompletedMarch 28, 2025
March 1, 2025
4.8 years
March 26, 2018
April 12, 2024
March 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Bodyweight
Percent bodyweight change (clinic measured) of participant
12-month change from baseline bodyweight
Change in Bodyweight
Percent bodyweight change (clinic measured) of participant
18-month change from baseline bodyweight
Change in Bodyweight
Percent bodyweight change (clinic measured) of participant.
24-month change from baseline bodyweight
Secondary Outcomes (22)
Change in Waist Circumference
12-month.change from baseline waist circumference
Change in Waist Circumference
24-month change from baseline waist circumference
Change in Fasting Glucose
12-month change from baseline fasting glucose
Change in Fasting Glucose
24-month change from baseline fasting glucose
Change in Fasting Insulin
12-month change from baseline fasting insulin
- +17 more secondary outcomes
Other Outcomes (4)
Change in Health Related Quality of Life
12-month change from baseline SF-12 score: PCS component and MCS component
Change in Health Related Quality of Life
24-month change from baseline SF-12 score: PCS and MCS
Change in Mood
12-month change from baseline CES-D
- +1 more other outcomes
Study Arms (2)
DPP Plus 30-minute calls
ACTIVE COMPARATORFollowing the 6-month, 16-session, DPP core program, 30-minute group telephone calls will be implemented. Structured behavioral DPP maintenance sessions with a healthy aging focus occur once-per-month from months 7 to 12, and every-two-months from months 13 to 24.
DPP Minimal 15-minute calls
PLACEBO COMPARATORFollowing the 6-month, 16-session, DPP core program, 15-minute group telephone calls will be implemented. Social-support sessions occur once-per-month from months 7 to 12, and every-two-months from months 13 to 24.
Interventions
Ongoing DPP intervention and behavioral progress review to prevent relapse and improve cardiometabolic and functional health targets as keys to healthy aging.
No further behavioral intervention materials provided; phone-contacts for mutual social support and accountability
Eligibility Criteria
You may qualify if:
- Men and women
- Ages 60 and older
- Body mass index (BMI) \>= 27 kg/m2
- Prediabetes defined as Hemoglobin (HbA1c) \>= 5.7 % and \<= 6.4 % or fasting glucose of \>= 100 mg/dL and less than 126 mg/dL (at either screening or baseline visit)
- Access to a telephone (for group calls) and to video-player or computer with Internet (to watch session videos and activity videos)
- Able to travel to one of the community clinics in Southwestern Pennsylvania to participate in the first four in-person intervention sessions and five health assessments at 0, 6, 12, 18, and 24 months
- Has health care provider permission to participate
You may not qualify if:
- Currently diagnosed with diabetes (defined as HbA1c of \>= 6.5% at either screening or baseline visit)
- Currently taking glucose lowering medications or weight loss medications
- Weight loss of 9 pounds or more in the last six months
- History of bariatric surgery within the last 2 years
- Permanently confined to wheelchair
- Significant cognitive or psychiatric disability that would preclude participation in normal community-based educational activities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Univ. Pittsburgh School of Medicine-Dept. Psychiatry
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
The study is likely underpowered for the primary outcome of weight change, due to recruitment targets not being met during the Covid-19 pandemic and greater than expected loss to follow-up for objective measurements in clinic (starting March 2020).
Results Point of Contact
- Title
- Elizabeth M. Venditti PhD, Associate Professor of Psychiatry and Epidemiology
- Organization
- University of Pittsburgh School of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth M Venditti, PhD
Univ. Pittsburgh School of Medicine-Dept. Psychiatry
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Psychiatry and Epidemiology
Study Record Dates
First Submitted
March 26, 2018
First Posted
April 18, 2018
Study Start
March 27, 2018
Primary Completion
January 27, 2023
Study Completion
May 1, 2023
Last Updated
March 28, 2025
Results First Posted
August 15, 2024
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- 3 years from the final data collection of the last participant
- Access Criteria
- Investigators will share data through the NIDDK central repository (website shown below)
Investigators will follow the guidance of NIDDK on data preparation and sharing policies and insure there is permission to disclose de-identified individual participant-level data collected prior to releasing it to other researchers. In addition, requesting researchers must meet all NIDDK access requirements. Study investigators will maintain strict compliance with Human Research Protections/IRB requirements and use appropriate safeguards before sharing any IPD with other researchers. Within 3 years following final data collection, the investigators will prepare and share the final, completely de-identified dataset (IPD) with NIDDK to be made available to other researchers. However, the investigators will not share other statistical code or data dictionaries.